EyewireTV

04.24.2024

Watch Episode

Stocks

Sort by:

Change A-Z

AbbVie $160.86 -3.85%

Adverum Biotechnologies $9.72 3.46%

Alcon $78.80 -0.05%

Aldeyra Therapeutics $3.88 -1.65%

Alimera Sciences $3.45 4.23%

Apellis Pharmaceuticals $49.94 4.19%

Astellas Pharma $9.54 0.74%

Bausch + Lomb $14.73 -0.24%

Bausch Health Companies $8.73 1.22%

Bayer $7.27 0.14%

Biogen $206.17 1.83%

Can-Fite Biopharma $1.92 -1.03%

Clearside Biomedical $1.30 3.17%

Cooper Companies $89.94 0.01%

Eyenovia $0.69 -2.63%

EyePoint Pharmaceuticals $15.93 -1.45%

Glaukos $99.14 -0.97%

Harrow Health $10.48 4.80%

Hill-Rom $155.96 0.03%

Horizon Therapeutics $116.30 0.00%

InMed Pharmaceuticals $0.24 -3.17%

Iridex Corporation $2.96 0.68%

Johnson & Johnson $146.40 -0.29%

Kala Pharmaceuticals $6.09 -1.46%

Kiora Pharmaceuticals $0.47 -1.46%

Lensar $3.43 5.21%

Lineage Cell Therapeutics $1.13 1.35%

MeiraGTx Holdings $4.84 2.76%

Merck & Company $131.19 0.36%

National Vision Holdings $17.93 0.34%

NovaBay Pharmaceuticals $0.08 9.87%

Novartis AG Common Stock $98.03 -1.04%

Ocugen $1.24 4.66%

Ocular Therapeutix $4.14 -1.55%

Oculis $11.95 -0.25%

Ocuphire Pharma $1.58 2.93%

Omeros Corp. $3.06 0.66%

Osmotica $1.11 -1.77%

Outlook Therapeutics $8.19 -0.12%

Palatin Technologies $1.72 -0.58%

Regeneron $881.51 -1.03%

Regenxbio $16.23 1.06%

Roche $30.02 -1.70%

Sight Sciences $5.18 0.78%

STAAR Surgical Company $47.10 0.45%

Takeda Pharmaceutical Company $13.02 -0.42%

Tarsus Pharmaceuticals $32.08 -0.40%

Viatris $11.55 0.70%

View More Stocks

Cataract

Dense Cataract in Pseudoexfoliation Syndrome

Marisa Schoen, MD

Eyetube

Marisa Schoen, MD, presents a case of dense cataract with pseudoexfoliation syndrome. The patient presented with an inferiorly subluxated mature brunescent cataract with significant phacodonesis. Dr. Shoen demonstrates her surgical approach to cataract extraction and IOL implantation with the use of a capsular tension ring and iris hook to stabilize the capsular bag during capsulorhexis.

Chandelier Retroillumination in a Complex Cataract Extraction

Birkaran Sadhar, and Eric D. Rosenberg, DO, MScEng

Eyetube

OMDI as an Alternative to Prostaglandin Analogues in Low or Nonresponders

Joseph F. Panarelli, MD; and Neda Shamie, MD

Eyetube

IOL Fixation Using Gore-Tex Four-Point Fixation of a Single Piece IOL

Samuel Hobbs, MD

Eyetube

High Astigmatism and Amblyopia

What are the options for improving the vision of this young patient?

Pavel Stodulka, MD, PhD; Brett Mueller, DO, PhD; Stefanie Schmickler, MD; and Abi Tenen, MBBS(Hons), FRANZCO

Cataract and Refractive Surgery Today

Combining Vitreoretinal Surgery With EDOF IOL Implantation

The lens technology’s potential to reduce patients’ trips to the OR and loss of accommodation.

Peter Stalmans, MD, PhD

Cataract and Refractive Surgery Today

04.25.2024

Bausch + Lomb Announces Results of Study Examining its New Daily Nutritional Supplement for Dry Eyes

Eyewire News

04.19.2024

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

Eyewire News

Refractive

Beyond DEWS II

An overview of the latest advances in dry eye disease management, treatment innovations, and insights into the condition’s pathophysiology since the landmark TFOS DEWS II report.

Quillan M. Austria, MD, and Christopher E. Starr, MD

Cataract and Refractive Surgery Today

In 2017, the Tear Film and Ocular Surface Society (TFOS) published the TFOS Dry Eye Workshop II (DEWS II) in The Ocular Surface.1-9 The objectives were to update the definition of dry eye disease (DED) established in DEWS I and critically review and integrate the substantial volume of literature on various aspects of DED, including risk factors, pathophysiology, management, and future therapies. Since the publication of DEWS II, the field of DED has grown considerably, with more than 8,000 studies added to the literature. This article highlights some of the significant advances since the publication of DEWS II and seeks to increase awareness of future interventions in DED treatment.

Hear the Journey of the OD Behind the Crystal Tear Report

Eyetube

An Eye to the Future

Steve Speares tells CRST what lies ahead for the ASCRS.

Gillian McDermott, MA, Editor-in-Chief, Clinical Content, Anterior Segment, BMC Vision

Cataract and Refractive Surgery Today

The Benefits of a “Boring” Day

Paul Walton, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD

Eyetube

The Development and Impact of the Malyugin Ring

The journey of a groundbreaking device in cataract surgery that revolutionized pupillary dilation techniques.

Boris Malyugin, MD, PhD

Cataract and Refractive Surgery Today

Unraveling the Role of Accessory Lacrimal Glands

Learn about the big effect these small glands have on dry eye dynamics.

Srinivas S. Kondapalli, MD; Nandini Venkateswaran, MD; and Ada Noh, OD

Cataract and Refractive Surgery Today

04.25.2024

Bausch + Lomb Announces Results of Study Examining its New Daily Nutritional Supplement for Dry Eyes

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Stay Updated

Retina

The Importance of Serial OCT Scans in Tractional Retinal Detachment

Ahmed Abdelshafy, MD

Eyetube

In this video, Ahmed Abdelshafy, MD, shows the importance of serial OCT scans in cases of vitreomacular traction. In this case, Dr. Abdelshafy performs tractional retinal detachment repair in the eye of a 55-year-old patient.

Ocular Effects of CAR-T Cell Therapy

Know the risks and potential therapeutic benefits associated with this treatment modality.

Lars H. Andersen, MD; Jaskirat S. Takhar, MD; and Jose J. Echegaray, MD

Retina Today

Uveal Reactive Lymphoid Hyperplasia

Be on the lookout for this rare cause of choroidal lesions.

Loka Thangamathesvaran, MD, and J. Fernando Arevalo, MD, PhD

Retina Today

Multimodal Imaging in Uveitis

Recent imaging advances have improved our ability to diagnose and monitor this challenging condition.

Eric Jung, MD, and Sumit Sharma, MD

Retina Today

Practice Makes Progress

Marion Munk, MD, and Justis P. Ehlers, MD

Retina Today

Successful Management of Vitreous Opacities

Eyetube

04.26.2024

Aldeyra Therapeutics Announces Planned Pivotal Clinical Trial for Retinitis Pigmentosa Drug Candidate

Eyewire News

04.25.2024

RevOpsis Secures $16.5 Million Seed Funding to Advance First-in-Class Tri-Specific Therapy for Wet AMD Treatment

Eyewire News

04.25.2024

Bausch + Lomb Announces Results of Study Examining its New Daily Nutritional Supplement for Dry Eyes

Eyewire News

04.23.2024

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

Eyewire News

Glaucoma

Genetics: Now or Later?

Why it’s time to know the basics.

Inas F. Aboobakar, MD

Glaucoma Today

Genetic factors contribute to the development of all forms of early- and adult-onset glaucoma, and recent studies have identified gene variants for every form of disease.1 In coming years, this genetic information will likely have a role in clinical glaucoma care (and ophthalmology and medicine in general), so it is important to be familiar with the basics. The vision for this field is to one day be able to collect a blood sample from any given patient who presents to clinic and run a gene panel to identify the gene mutations or risk variants they carry. For early-onset forms of glaucoma, such as congenital glaucoma and juvenile open-angle glaucoma, testing could identify the causal gene mutation responsible for disease development. First-degree relatives could then be screened for that gene mutation to determine if they are also carriers and therefore warrant close monitoring. Ultimately, it may also be possible to offer these patients targeted gene therapies. For adult-onset forms of glaucoma, such as primary open-angle glaucoma (POAG), angle closure, and exfoliation glaucoma, many genes are associated with small increases in disease risk. These gene variants can be assessed in aggregate by deriving a polygenic risk score (PRS), which can provide information on an individual’s glaucoma risk relative to the general population. This may allow personalized risk assessment, monitoring, and therapy for patients with glaucoma and glaucoma suspects. In addition, understanding the specific genetic drivers for a given patient may enable us to classify them into disease subtypes. EARLY-ONSET GLAUCOMA For early-onset forms of glaucoma (patient age at onset ≤ 40 years), a single gene mutation is sufficient for disease development.

Ahmed DVX Prism for ORA and Hydrus Cases

Arkadiy Yadgarov, MD

Eyetube

Reflections on Fellowship So Far

With half a year behind them, current glaucoma fellows share their favorite pearls to date.

Viviana Barquet, MD; Gio Campagna, MD; Teresa Horan, MD; and Timothy Truong, MD

Glaucoma Today

Establishing a Glaucoma Practice Fresh Out of Fellowship

Emily Schehlein, MD

Eyetube

iTrack Canaloplasty With 90° Goniotomy

I. Paul Singh, MD

Eyetube

DARC: From Bench to Bedside

Tracing the path of an exploratory retinal biomarker.

Francesca M. Cordeiro, MD, PhD, MRCP, FRCOphth

Glaucoma Today

04.25.2024

Bausch + Lomb Announces Results of Study Examining its New Daily Nutritional Supplement for Dry Eyes

Eyewire News

04.24.2024

LEP Biomedical Closes Pre-Seed Funding to Advance HyaGuard Platform

Eyewire News

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Pupil Pod

A case-based podcast hosted by Sila Bal, MD, MPH, featuring all stages of the journey through ophthalmology, from first-year residents to the leading experts.

View Feed

Optometry

Realize the Power of Comanagement

Build community with your local providers to ensure your patients receive the best possible care.

Jeff Banas, OD

Modern Optometry

I am embarrassed to admit it took me a while to truly appreciate the value of social networking, but it is now integral to how I practice optometry. To clarify, when I use the term social networking, I am not referring to social media, although that has its place. Rather, I mean the building of real, lasting relationships based on personal interactions. In the health care industry, networking can come in many forms, from establishing mentors to meeting colleagues and friends across various specialties. Many clinicians focus on what we alone can do for our patients, and we are proud of our abilities to treat and manage various conditions, much to the joy of our patients. However, as the scope of optometric care continues to grow, more of us are becoming more specialized. My practice focuses heavily on refractive surgery, glaucoma, and the anterior segment. We do provide comprehensive eye care, but we refer out for certain conditions. I am knowledgeable about the retina, but I have no problem telling a patient that I would like my retina colleague’s second opinion on what I’m seeing. I view comanagement as an extension of my knowledge base that I use to ensure my patients receive the best care possible.

The State of Optometry’s Financial Health

Five takeaways from the largest income survey conducted in optometry.

Aaron Neufeld, OD

Modern Optometry

The Mystery of Cilioretinal Arteries and AMD

Research is beginning to unravel the role these arteries play in the pathogenesis of neovascularization.

Adel Ebraheem, MD, MS, OD

Modern Optometry

GA Case Compendium: Multimodal Imaging for Following Geographic Atrophy Over Time

Julie Rodman, OD, MSc, FAAO, FORS

Modern Optometry

Behold, the Power to Reverse Mydriasis Is Here!

The wait is finally over.

Modern Optometry

The Promise of Drug-Eluting Contact Lenses

The future looks bright for this technology.

Alex Hynes, OD, FAAO

Modern Optometry

04.25.2024

World Council of Optometry and CooperVision Partner on Myopia Management Navigator Educational Resource

Eyewire News

04.23.2024

DigitalOptometrics Surpasses 2 Million Remote Eye Exams

Eyewire News

04.10.2024

Orbis Partners and Heidelberg Engineering Partner to Train Eye Care Professionals Around the World

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Business

Interprofessional Collaboration Pays Off

Working alongside a patient’s primary care physician, the author was able to diagnose Sjögren syndrome and refer her for proper care.

Naureen M. Haroon, OD, MPH, FAAO

Modern Optometry

I was surprised to learn my new 62-year-old patient had been complaining about severe dry mouth to her primary care physician for the past 15 years with no relief. Year after year, she was advised to use mouth moisturizing tablets or a spray, and sent home. But when I heard her complaints of long-standing dry eyes and a dry mouth, I immediately thought of Sjögren syndrome (SS). These two symptoms don’t always indicate SS—especially considering the patient had no other underlying autoimmune conditions, such as systemic erythematous lupus or rheumatoid arthritis, as seen in secondary SS—but it should always be considered and ruled out. THE PATIENT ENCOUNTER While in my examination chair, I noticed the patient had a dry cough. She excused herself to grab a cough drop from her purse, which she explained was a daily occurrence. We discussed possible systemic and environmental factors that could exacerbate her dry eye signs and symptoms, and I started her on lifitegrast ophthalmic solution 5% (Xiidra, Bausch + Lomb) twice daily and fish oil. I also gave her a sample of artificial tears. We talked about punctal plugs, and I advised her to reach out to her primary care physician to request testing for SS. Following up, I sent a simple letter to the patient’s primary care physician, discussing my exam findings and my concern for SS.

Expand Your Opportunities for Profitability

Consider adding these technologies to your practice and reap the rewards.

Christopher Lopez, OD

Modern Optometry

Achieving Staffing Excellence

Master this cornerstone of practice success by defining each staff member’s specific role.

Jason E. Compton, OD, FAAO

Modern Optometry

How Digital Health Helps Differentiate Your Optometric Practice

Understand what digital health is and learn how it can distinguish your clinic now and in the future.

Timothy Earley, OD

Modern Optometry

The Good Life

Selina R. McGee, OD, FAAO; Justin Schweitzer, OD, FAAO; and Walter O. Whitley, OD, MBA, FAAO

Modern Optometry

Technology in Collaborative Care: Friend or Foe?

Leveraging advances in optometry will help deliver more optimal, efficient patient care.

Selina R. McGee, OD, FAAO

Modern Optometry

04.25.2024

RevOpsis Secures $16.5 Million Seed Funding to Advance First-in-Class Tri-Specific Therapy for Wet AMD Treatment

Eyewire News

04.24.2024

LEP Biomedical Closes Pre-Seed Funding to Advance HyaGuard Platform

Eyewire News

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

Eyewire News

04.16.2024

EyeSouth Partners Affiliates With Community Eye Care Specialists in New York

Eyewire News

EyewireTV

04.24.2024

04.24.2024

Executive Updates

Johnson & Johnson Vision

Zeiss

Staar Surgical

Nordic Pharma

ViaLase

Lensar

Epion Therapeutics

Eyewire News

Aldeyra Therapeutics Announces Planned Pivotal Clinical Trial for Retinitis Pigmentosa Drug Candidate

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

RevOpsis Secures $16.5 Million Seed Funding to Advance First-in-Class Tri-Specific Therapy for Wet AMD Treatment

Stocks

Cataract

Dense Cataract in Pseudoexfoliation Syndrome

Chandelier Retroillumination in a Complex Cataract Extraction

OMDI as an Alternative to Prostaglandin Analogues in Low or Nonresponders

IOL Fixation Using Gore-Tex Four-Point Fixation of a Single Piece IOL

High Astigmatism and Amblyopia

Combining Vitreoretinal Surgery With EDOF IOL Implantation

04.25.2024

Bausch + Lomb Announces Results of Study Examining its New Daily Nutritional Supplement for Dry Eyes

04.19.2024

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

Refractive

Beyond DEWS II

Hear the Journey of the OD Behind the Crystal Tear Report

An Eye to the Future

The Benefits of a “Boring” Day

The Development and Impact of the Malyugin Ring

Unraveling the Role of Accessory Lacrimal Glands

04.25.2024

Bausch + Lomb Announces Results of Study Examining its New Daily Nutritional Supplement for Dry Eyes

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Stay Updated

Follow Eyewire News

Retina

The Importance of Serial OCT Scans in Tractional Retinal Detachment

Ocular Effects of CAR-T Cell Therapy

Uveal Reactive Lymphoid Hyperplasia

Multimodal Imaging in Uveitis

Practice Makes Progress

Successful Management of Vitreous Opacities

04.26.2024

Aldeyra Therapeutics Announces Planned Pivotal Clinical Trial for Retinitis Pigmentosa Drug Candidate

04.25.2024

RevOpsis Secures $16.5 Million Seed Funding to Advance First-in-Class Tri-Specific Therapy for Wet AMD Treatment

04.25.2024

Bausch + Lomb Announces Results of Study Examining its New Daily Nutritional Supplement for Dry Eyes

04.23.2024

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

Glaucoma

Genetics: Now or Later?

Ahmed DVX Prism for ORA and Hydrus Cases

Reflections on Fellowship So Far

Establishing a Glaucoma Practice Fresh Out of Fellowship

iTrack Canaloplasty With 90° Goniotomy

DARC: From Bench to Bedside

04.25.2024

Bausch + Lomb Announces Results of Study Examining its New Daily Nutritional Supplement for Dry Eyes

04.24.2024

LEP Biomedical Closes Pre-Seed Funding to Advance HyaGuard Platform

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Featured Podcasts

Ophthalmology off the Grid